2/ The authors used their previously developed myocardial matrix hydrogels derived from decellularized and lyophilized porcine ventricle. A Phase I trial using these hydrogels in post-MI LV dysfunction was previously published in #JACCBTS. 👇 https://t.co/F
RT @musclecellnews: And #1 in our Top Tweets countdown... A clinical trial establishing the safety and feasibility of VentriGel in myocardi…
And #1 in our Top Tweets countdown... A clinical trial establishing the safety and feasibility of VentriGel in myocardial infraction patients! https://t.co/QECZ0IGylh
RT @JACCJournals: Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patient…
RT @JACCJournals: Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patient…
RT @JACCJournals: Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patient…
RT @JACCJournals: Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patient…
RT @JACCJournals: Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patient…
Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patients with a late #cvMI is presented in the latest issue of #JACCBTS. https://t.co/5qmAyeIJdz https://t.co/Y1z2kz8Egv
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients. https://t.co/qcKMPQrQSo
RT @musclecellnews: New publication from @MHIF_Heart and @DignityHealthAZ researchers | First-in-man study of a #cardiac extracellular mat…
New publication from @MHIF_Heart and @DignityHealthAZ researchers | First-in-man study of a #cardiac extracellular matrix hydrogel in early and late #HeartAttack patients. https://t.co/WK3ptwFhG6
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
❤ interesting paper #BSEcho #cardiacPhysiology
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @cladelucia: #JACCBTS : Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes i…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
Very interesting. We’ll see how this pans out.
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
RT @AspriAlexia: This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients an…
This novel phase study -first in man established the safety and feasibility of delivering VentriGel in post-MI patients and may improve outcomes in these patients.Thus, warranting further evaluation in larger, randomized clinical trials. #STEMI #Cardiology
#JACCBTS : Novel phase I study showing that an injectable extracellular matrix is safe in humans and may improve outcomes in patients with a late #myocardial #infarction. #molecular #cardiology #cardiotwitter #cardiologist #Science #research @JACCJournals
Hey @BEaTSResearch, did you see this? How cool! Biomaterials for the win! https://t.co/dyw5ZlYdeI
hydrogel matrices not only help to repair damaged heart tissue but also promotes functional restoration https://t.co/vLAf5MGjDP #Science #medicine #cardiology
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
Super cool that this report also mentions new work from Karen Christman's lab at @UCSDJacobs who is using injectable hydorgels for treatment after MI and recently had a paper out on their initial clinical trials: https://t.co/DsHPRfV0Pq
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
Top👌🏻
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early... https://t.co/9WTQFCIXPw
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @fitmslax: Ventrix has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
RT @AspriAlexia: What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine m…
What are the outcomes of transendocardial injection of extracellular matrix hydrogel derived from decellularized porcine myocardium in #MyocardialInfarction patients?The first in-man of a cardiac extracellular matrix in both early and late MI. Learn more:
Reading, "1st human use of cardiac extracellular matrix hydrogel in myocardial infarction" https://t.co/IEqVuAZLVm
RT @serotonin_nin: 心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られ…
1st human use of cardiac extracellular matrix hydrogel in myocardial infarction https://t.co/OwH2XPoEOk
RT @420Cyber: 1st human use of cardiac extracellular matrix hydrogel in myocardial infarction https://t.co/yX4nCkVGdo
1st human use of cardiac extracellular matrix hydrogel in myocardial infarction: https://t.co/Fja2WpIuCs Comments: https://t.co/GT9sOfZGcS
1st human use of cardiac extracellular matrix hydrogel in myocardial infarction https://t.co/LOedYN85A2 (cmts https://t.co/ocsyVdhO87)
1st human use of cardiac extracellular matrix hydrogel in myocardial infarction https://t.co/yX4nCkVGdo
1st human use of cardiac extracellular matrix hydrogel in myocardial infarction L: https://t.co/ALzZKxGSM6 C: https://t.co/Ci1q7rEKdz
RT @serotonin_nin: 心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られ…
RT @serotonin_nin: 心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られ…
RT @serotonin_nin: 心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られ…
RT @serotonin_nin: 心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られ…
RT @serotonin_nin: 心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られ…
心臓組織を修復するために作られたハイドロゲルの最初の臨床実験が成功しました。注射可能なヒドロゲルの臨床実験です。 ハイドロゲルを、過去2〜36か月間に心臓発作を起こした患者にカテーテルを介して安全に注入したところ心機能が改善する徴候が見られたそうです🌈 https://t.co/oFNAt2ZmrL
梗塞心筋に注入して修復を加速するブタ心筋由来無細胞間質ハイドロゲル（＃VentriGel ）がP1を通過。有効性も見えるようだ、と： Sanford Consortium for Regenerative Medicine。 https://t.co/0nPpwk9a3o
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @AnastasiaSMihai: So pleasing to see #biomedical #discovery #science translate to treatment & recall the early research in this field as…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @AnastasiaSMihai: So pleasing to see #biomedical #discovery #science translate to treatment & recall the early research in this field as…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @AnastasiaSMihai: So pleasing to see #biomedical #discovery #science translate to treatment & recall the early research in this field as…
RT @AnastasiaSMihai: So pleasing to see #biomedical #discovery #science translate to treatment & recall the early research in this field as…
RT @AnastasiaSMihai: So pleasing to see #biomedical #discovery #science translate to treatment & recall the early research in this field as…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
So pleasing to see #biomedical #discovery #science translate to treatment & recall the early research in this field as I am sure you did @shiang_lim @merrylindseyphd "First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early & Late M
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
First-in-Man Study of a Cardiac Extracellular Matrix Hydrogel in Early and Late Myocardial Infarction Patients https://t.co/9uen8TMUEu
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
+ve outcomes in this 1st in man hydrogel injection post MI study, exciting stuff.
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @MHIF_Heart: Hot off the press! Dr. Jay Traverse's paper discusing early safety and feasibility of injecting #VentriGel made of ECM from…
Hot off the press! Dr. Jay Traverse's paper discusing early safety and feasibility of injecting #VentriGel made of ECM from porcine hearts ! Check out the details online: https://t.co/atcTOBoSAx
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…
RT @JACCJournals: Is the injection of a cardiac extracellular matrix (ECM) hydrogel in early & late #cvMI patients safe & feasible? #JACCBT…